Eyefluence: Envisioning Solutions

Peter Lycurgus had an opportunity to invest in Eyefluence, a start-up venture whose eye-tracking technology allowed individuals to operate digitally controlled devices through eye movements. Eyefluence needed financing to refine its technology with added capabilities, produce the first small production run, and increase market awareness of the product.  Peter had previously invested in Series A and B funding for several early-stage technology companies and worked in technology himself before retiring with multiple sclerosis.  He had seen Eyefluence’s prototype glasses demonstrated and now contemplated whether to provide early-stage funding for a firm whose first target was the assistive technology market.  Should he invest in Eyefluence in the first rounds of financing? If so, what was the company worth?  The firm would likely need additional financing.  Would he need to consider investing in later rounds too?